COROMANDEL INTERNATIONAL LTD.

Coromandel International Limited announced its Q1 FY27 financial results, reporting a 10% increase in total income to ₹7,792 crore on a standalone basis and 15% to ₹8,215 crore on a consolidated basis. However, net profit saw a significant decline of 26% to ₹377 crore (standalone) and ₹382 crore (consolidated). This downturn is attributed to elevated raw material costs stemming from the Middle East crisis, impacting the Fertiliser business, while subsidy rates remained inadequate. The company highlighted progress in key initiatives, including the stabilization of new acid plants and ongoing expansion projects. The Crop Protection business showed strong performance with a 20% revenue growth and 44% EBITDA increase, driven by exports and B2B sales. The retail segment also continued its growth trajectory.

Coromandel International Ltd announced the approval of its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors, following the recommendation of the Audit Committee, approved both standalone and consolidated results. The company also disclosed key corporate actions, including the conversion of a loan of approximately ₹108 Crores into equity shares in its wholly-owned subsidiary, Coromandel Chemicals Limited. Additionally, the Board approved the restructuring of loans amounting to USD 9.70 Million in its step-down subsidiary, Baobab Mining and Chemicals Corporation S A (BMCC), into equity or preference shares.

Coromandel International Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results. The company also disclosed the conversion of a loan of approximately ₹108 Crores to equity in its wholly-owned subsidiary, Coromandel Chemicals Limited. Additionally, a restructuring of USD 9.70 Million in loans given to step-down subsidiary Baobab Mining and Chemicals Corporation S A (BMCC) into equity or preference shares was approved.

Coromandel International Ltd has announced that its Board of Directors will convene on July 23, 2026. The primary agenda item for this meeting is to consider and approve the company's Unaudited Financial Results for the quarter ended June 30, 2026. The results will be presented on both a standalone and consolidated basis. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Coromandel International Limited has achieved the Responsible Care Certification from the Indian Chemical Council (ICC), effective from April 2026 to March 2029. This certification covers all 18 manufacturing facilities across its Nutrients, Crop Protection Chemicals, Specialty Nutrients, and Bio businesses. The recognition signifies adherence to global chemical industry standards for safety, health, environmental protection, product stewardship, and security. The company underwent a rigorous assessment and implemented improvements in process safety, employee wellbeing, environmental performance, and community engagement. This achievement positions Coromandel among a select group of companies globally meeting these stringent criteria.

Coromandel International Ltd has attached its Integrated Annual Report for FY 2025-26, along with the notice for its 64th Annual General Meeting (AGM) and the Business Responsibility and Sustainability Reporting (BRSR). The AGM is scheduled for Thursday, July 23, 2026, at 3:30 PM IST, to be held via video conferencing. The report, sent electronically to members, covers the company's financial, operational, and ESG performance, aligning with IIRC principles, GRI Standards, and BRSR framework. Key dates for e-voting and book closure have also been provided.

Coromandel International Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent potential insider trading during periods when material non-public information may be available.

Coromandel International has responded to a BSE query regarding a media report about an MoU with Samunnati Agri Value Chain to aid FPOs. The company stated the report was based on a general press release and the MoU does not meet materiality thresholds for disclosure. Coromandel confirmed no undisclosed material information exists that could explain trading movements and attributed any price fluctuations to market conditions. The company also confirmed the MoU has no immediate material impact on its business, operations, or financial position.

Coromandel International Ltd announced its FY26 results, reporting a 30% increase in total income to ₹31,827 Cr and a 23% rise in EBITDA to ₹3,232 Cr. PAT decreased by 8% to ₹1,898 Cr. The company declared a final dividend of ₹2 per share, bringing the total dividend for FY26 to ₹11 per share. Key initiatives included commissioning new Sulphuric and Phosphoric Acid plants and expanding agri-retail network to 1200 centers.

Coromandel International Ltd has re-appointed M/s. S R Batliboi & Associates LLP as Statutory Auditors for a second term of five years, subject to shareholder approval at the upcoming 64th Annual General Meeting. The board also approved the audited financial results for the quarter and year ended March 31, 2026, declared a final dividend of ₹2 per equity share, and approved convening the 64th AGM on July 23, 2026.